299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00157690 (ClinicalTrials.gov)	December 2003	8/9/2005	Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients	A Multicentre, Double-Blind, Randomized Placebo-Controlled Study of 70mg Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients	Cystic Fibrosis;Osteoporosis;Bone Diseases, Metabolic	Drug: Alendronate;Drug: Placebo	McMaster University	Centre hospitalier de l'Université de Montréal (CHUM);London Health Sciences Centre;University of Calgary;McGill University;Laval University;Merck Frosst Canada Ltd.	Completed	18 Years	N/A	Both	56	Phase 4	Canada
2	NCT01812551 (ClinicalTrials.gov)	October 2002	14/3/2013	Treatment of Low Bone Density in Cystic Fibrosis.	Osteoporosis in Cystic Fibrosis: Study of Bone Mass and Bone Metabolism, and Prospective Randomized Therapeutic Trial.	Osteoporosis;Cystic Fibrosis	Drug: Alendronate;Drug: Placebo	Istituto Auxologico Italiano	Fondazione Telethon	Completed	5 Years	30 Years	Both	171	Phase 3	Holy See (Vatican City State);Italy
3	NCT00004489 (ClinicalTrials.gov)	October 1998	18/10/1999	Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis		Osteoporosis;Cystic Fibrosis	Drug: alendronate sodium;Drug: calcium carbonate;Drug: cholecalciferol	University of North Carolina	NULL	Completed	18 Years	45 Years	Both	60	N/A	United States